Literature DB >> 28836020

Change of the N-terminal codon bias combined with tRNA supplementation outperforms the selected fusion tags for production of human D-amino acid oxidase as active inclusion bodies.

Weiyu Wang1, Jiaqi Sun1, Wenjun Xiao1, Li Jiang1, Ruyue Wang1, Jun Fan2.   

Abstract

OBJECTIVES: To optimize the production of active inclusion bodies (IBs) containing human D-amino acid oxidase (hDAAO) in Escherichia coli.
RESULTS: The optimized initial codon region combined with the coexpressed rare tRNAs, fusion of each of the N-terminal partners including cellulose-binding module, thioredoxin, glutathione S-transferase and expressivity tag, deletion of the incorporated linker, and improvement of tRNA abundance affected the production and activity for oxidizing D-alanine of the hDAAO in IBs. Compared with the optimized fusion constructs and expression host, IBs yields and activity were increased to 2.6- and 2.8-fold respectively by changing the N-terminal codon bias of the hDAAO. The insoluble hDAAO codon variant displayed the same substrate specificity as the soluble one for oxidizing D-alanine, D-serine and D-aspartic acid. The freshly prepared hDAAO codon variant was used for analyzing the L-serine racemization activity of the bacterially expressed maize serine racemase.
CONCLUSIONS: Optimization of the N-terminal codon bias combined with the coexpression of rare tRNAs is a novel and efficient approach to produce active IBs of the hDAAO.

Entities:  

Keywords:  Active inclusion bodies; Codon bias; D-Amino acid oxidase; Escherichia coli; Fusion tag; Human D-amino acid oxidase; Rare tRNAs

Mesh:

Substances:

Year:  2017        PMID: 28836020     DOI: 10.1007/s10529-017-2413-3

Source DB:  PubMed          Journal:  Biotechnol Lett        ISSN: 0141-5492            Impact factor:   2.461


  1 in total

Review 1.  Catalytically-active inclusion bodies for biotechnology-general concepts, optimization, and application.

Authors:  Vera D Jäger; Robin Lamm; Kira Küsters; Gizem Ölçücü; Marco Oldiges; Karl-Erich Jaeger; Jochen Büchs; Ulrich Krauss
Journal:  Appl Microbiol Biotechnol       Date:  2020-07-10       Impact factor: 4.813

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.